68
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube

, , , , &
Pages 91-93 | Published online: 25 Nov 2022

Figures & data

Figure 1 Slit lamp photographs of superotemporal bulbar conjunctiva of the left eye. (A) Before the intravitreal tPA injection, conjunctiva was flat over the Ahmed plate. Note the pericardium (Tutoplast, Costa Mesa, CA) and plate markings. (B) Two months following intravitreal tPA injection, there is a pseudocapsule over the functioning drainage device. Intraocular pressure is controlled with topical medications.

Figure 1 Slit lamp photographs of superotemporal bulbar conjunctiva of the left eye. (A) Before the intravitreal tPA injection, conjunctiva was flat over the Ahmed plate. Note the pericardium (Tutoplast, Costa Mesa, CA) and plate markings. (B) Two months following intravitreal tPA injection, there is a pseudocapsule over the functioning drainage device. Intraocular pressure is controlled with topical medications.

Figure 2 Slit lamp photographs of the left eye taken two months postoperatively. (A) Clear corneal graft with optic capture of a MA60AC (Alcon, Fort Worth, TX) intraocular lens. (B) The tip of the Ahmed tube in the anterior vitreous cavity is not occluded, as visualized by retroillumination.

Figure 2 Slit lamp photographs of the left eye taken two months postoperatively. (A) Clear corneal graft with optic capture of a MA60AC (Alcon, Fort Worth, TX) intraocular lens. (B) The tip of the Ahmed tube in the anterior vitreous cavity is not occluded, as visualized by retroillumination.